Rensselaer’s biotechnology initiative stands at the intersection of the life sciences, the physical and computer sciences, and engineering. In Biotechnology and the Life Sciences, we are creating new routes to drug discovery and development, and understanding the fundamental mechanisms of disease, from Alzheimer's, diabetes, osteoporosis and osteoarthritis, to cancer.
The research leaders who work, study, and innovate at Rensselaer share a common focus: unearthing new opportunities for solving the 21st century’s most challenging problems.
Right now, more than 6.5 billion people are competing for the Earth’s dwindling supply of fossil fuels. By 2050, there will be 8 to 10 billion, and major advances in energy technology will be required to meet their needs. Rensselaer has faced that challenge by launching and expanding programs in renewable energy sources and energy conservation.
In her speech at The Royal Academy of Engineering, Rensselaer President Shirley Ann Jackson spoke about the opportunities and challenges of Big Data.
“We ... have unprecedented capabilities in data access, aggregation, and analysis, and in high performance computation.
A new system planned for the Rensselaer Polytechnic Institute supercomputing center will enable exciting new research possibilities across the nation and boost the university’s international leadership in computational modeling and simulation, data science, high-performance computing, and web science.